iTeos Therapeutics, Inc. at its AGM on June 13, 2023 announced Detlev Biniszkiewicz, a member of the Board of Directors, notified the Company of his decision to resign from the Board, effective immediately. Dr. Biniszkiewiczâs resignation is not as a result of any disagreement between him and the Company, its management, the Board or any committee of the Board.
Real-time Estimate
Other stock markets
|
5-day change | 1st Jan Change | ||
14.89 USD | -2.36% |
|
-7.66% | +37.63% |
![Consensus](/images/consensus_flch.gif)
EPS Revisions
1st Jan change | Capi. | |
---|---|---|
+37.63% | 568M | |
+15.60% | 122B | |
+19.12% | 113B | |
+3.61% | 22.66B | |
-18.39% | 21.34B | |
-41.55% | 16.92B | |
-14.98% | 16.68B | |
-16.03% | 16.61B | |
+1.59% | 13.62B | |
+24.44% | 11.04B |
- Stock Market
- Equities
- ITOS Stock
- News iTeos Therapeutics, Inc.
- ITeos Therapeutics, Inc. Announces Resignation of Detlev Biniszkiewicz as Member of the Board of Directors